Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting earnings this Thursday before the bell.

Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report third-quarter fiscal 2025 results on Aug. 7, ...

BD (NYSE: BDX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus Wall Street ...

Becton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago. These ...

Becton, Dickinson (BDX) stock gains as the company boosts fiscal 2025 earnings outlook after better than expected Q3 results.

The stock's rise snapped a five-day losing streak.

This was the stock's fifth consecutive day of losses.

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...